ZOLGENSMA
ZOLGENSMA
Approved
DIN Number
02509695
Drug Class
Human
Market Date
Feb 4, 2021
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02509695
AIG Number0162641001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
M09AX09 ONASEMNOGENE ABEPARVOVEC
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification26:12.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ONASEMNOGENE ABEPARVOVECActive
Strength: 20000000000000 VG / ML
Monograph: ONASEMNOGENE ABEPARVOVEC